Home -> Law Blog Directory -> Patent Law Blogs -> IPBiz
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: IPBizAstraZeneca wins over Teva on Pulmincort in DNJ
By Lawrence B. Ebert, Esq.
The ruling may postpone the introduction of cheaper copies of the Respules version of Pulmicort in the U.S. The brand brought in $1.45 billion for AstraZeneca last year, while U.S. sales of Respules gained 20 percent from 2006.
Full post as published by IPBiz on September 24, 2008 (boomark / email).
Teva Animal Health Expands Ketamine Hydrochloride Recall
Teva Animal Health Expands Ketamine Hydrochloride Recall
FedEx
Ground Business Model Wins Class Action in Washington
Asbestos Mesothelioma Victim Wins Appeal of $20 Million Asbestos Cancer Verdict
Asbestos Mesothelioma Victim Wins Appeal of $20 Million Asbestos Cancer Verdict
Speedway Fatality
'Amazing Race' family wins lawsuit with Daytona Speedway.
Asbestos Mesothelioma Victim
Wins $16.5 Million Settlement
Facebook
Wins $873 Million Settlement

AstraZeneca Wins Seroquel Case on Summary Judgment; Teva and Sandoz to Appeal
D NJ ruling in favor of AstraZeneca in Seroquel case
Teva Intends to File Lawsuit Against Generic Filer for Patent Infringement
AstraZeneca Prevails in Seroquel® Paragraph IV Litigation
Teva Gets a Taste of Its Own Medicine
Jury orders AstraZeneca to pay $215 million for price inflations







